Advanced Enzyme Technologies Limited (BOM:540025)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Manufacturing and Sales of Enzymes	7.46B	6.37B	6.24B	5.41B	5.29B
Total	7.46B	6.37B	6.24B	5.41B	5.29B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	3.72B	2.91B	3.10B	2.55B	2.34B
Europe	398.48M	335.36M	397.80M	353.34M	377.39M
USA	2.19B	2.37B	2.09B	1.92B	2.09B
Asia (Ex-India)	903.99M	585.07M	439.70M	473.38M	331.79M
Rest of The World	235.80M	171.80M	207.77M	107.08M	150.87M
Total	7.45B	6.37B	6.23B	5.40B	5.29B

Data Source: S&P Global Market Intelligence Last updated: Aug 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 4, 2026

Data Sources Report a data error